Research

Life Sciences Cluster report Belgium

A growing sector offering multiple opportunities for landlords and occupiers

April 14, 2024

Contributors:

Pierre-Paul Verelst
Vincent Van Brée
Ralph Schellen *allres bv
Christophe Golenvaux *LWL Invest srl/bv
Steven Peeters *Streep bv

Life Sciences and biopharmaceuticals have long been key economic sectors in Belgium. They are supported by multiple tax and non-tax incentives from the governments, both federal and regional. Pharma multinationals like GSK, Pfizer, Sanofi as well as hundreds of smaller companies and start-ups demonstrated strong growth in recent years, hence playing an important role in the Belgian property market.

According to JLL, Ghent, Leuven and Louvain-La-Neuve / Wavre are the most attractive in terms of real estate investment, because of the links with internationally reputed universities, new projects and sufficient liquidity. As an illustration, international specialised funds have closed Life-Science property transactions in these markets over the past 5 years.

The report produced by JLL Research provides in-depth analysis of the main clusters active in Belgium.

Fill out this form to download report

I would like to receive communications from JLL.

There was an error submitting the form. Please try again.

PRIVACY NOTICE

Jones Lang LaSalle (JLL), together with its subsidiaries and affiliates, is a leading global provider of real estate and investment management services. We take our responsibility to protect the personal information provided to us seriously.

Generally the personal information we collect from you are for the purposes of dealing with your enquiry.

We endeavor to keep your personal information secure with appropriate level of security and keep for as long as we need it for legitimate business or legal reasons. We will then delete it safely and securely. For more information about how JLL processes your personal data, please view our privacy statement.